Presentations at the 9th AMR Conference and at ICDS 2024
Crestone had the opportunity to showcase its innovative research at the 9th AMR Conference in Basel, Switzerland, and ICDS 2024 in Bled, Slovenia.
Read More
CRS3123 for C. difficile
Presentation at ASM Microbe, Los Angeles, June 20, 2025: Microbiome Analysis of Fecal Samples Collected in a Phase 2 Clinical Trial Comparing CRS3123 Vs. Vancomycin to Treat C. difficile Infection
Crestone made an impact at the ASM Microbe 2025 conference in Los Angeles by presenting groundbreaking research on microbiome analysis.
Read More
Presentation at ESCMID Global, Vienna, April 15, 2025: CRS3123 with High Cure Rate and Low Recurrence In Toxin Positive Clostridioides difficile Infection
Crestone showcased their innovative work at the ESCMID Global conference in Vienna on April 15, 2025, highlighting CRS3123 for C. difficile infections.
Read More
Crestone Announces Positive Data from Phase 2 Clinical Trial of CRS3123 for C. Difficile Infections (CDI)
Primary endpoint met with high rates of clinical cure at day 12 Very low rates of recurrence...
Read More
Crestone Sponsors Peggy Lillis Foundation FIGHT C. DIFF. Gala
Crestone is proud to be a sponsor of the Peggy Lillis Foundation FIGHT C. DIFF. Gala in Brooklyn,...
Read More
Keystone Symposia: Antimicrobial Resistance & Microbiome Presentation
Keystone Symposia Presentation Details Poster: Phase 2 Clinical Trial Design for CRS3123, a Novel...
Read More
Presentation: World Antimicrobial Resistance (WAMR) Conference 2022
WAMR Conference 2022 Presentation Details Poster Presentation: Addressing the AMR Challenge:...
Read More
C. diff Infection Symptoms: An Overview
Clostridium difficile infection (CDI) is a gastrointestinal condition caused by toxin-producing...
Read More
Presentation at the 2022 National C. Diff Advocacy Summit
2022 National C. Diff Advocacy Summit Presentation Details Crestone presents at the largest...
Read More
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor, a team member, or a participant in our ongoing clinical studies.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a team-oriented environment at one of the leading Colorado pharma companies.
Investors
If you're interested in becoming an investor to help fund our research and development, contact us today.